Microbot Medical (MBOT) Equity Average (2016)
Microbot Medical's Equity Average history spans 6 years, with the latest figure at -$3.5 million for Q3 2016.
- For the quarter ending Q3 2016, Equity Average fell 131.34% year-over-year to -$3.5 million, compared with a TTM value of -$3.5 million through Sep 2016, down 131.34%, and an annual FY2013 reading of $14.5 million, up 17.11% over the prior year.
- Equity Average for Q3 2016 was -$3.5 million at Microbot Medical, up from -$5.9 million in the prior quarter.
- The five-year high for Equity Average was $12.1 million in Q1 2013, with the low at -$5.9 million in Q2 2016.
- Average Equity Average over 5 years is $5.4 million, with a median of $6.5 million recorded in 2015.
- Year-over-year, Equity Average surged 157.32% in 2013 and then plummeted 364.47% in 2016.
- Tracing MBOT's Equity Average over 5 years: stood at $11.6 million in 2012, then fell by 20.22% to $9.3 million in 2013, then fell by 10.33% to $8.3 million in 2014, then plummeted by 57.57% to $3.5 million in 2015, then crashed by 199.51% to -$3.5 million in 2016.
- Per Business Quant, the three most recent readings for MBOT's Equity Average are -$3.5 million (Q3 2016), -$5.9 million (Q2 2016), and -$3.5 million (Q1 2016).